Freeze dried cryoprecipitate: a clinical evaluation.

AUTOR(ES)

Hambley, H

RESUMO

Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.

Documentos Relacionados

• Freeze dried cryoprecipitate and home therapy.
• Production of freeze-dried human antihaemophilic cryoprecipitate.
• A clinical librarians' program--an attempt at evaluation.
• Perkins hand-held applanation tonometer. A clinical evaluation.
• Oral ampicillin in gonorrhoea. Clinical evaluation.